However, it seems that age can decrease the levels of this protein (Cont2 vs. Cont1 and PCa2 vs. PCa1), suggesting that RBP4 may be a urinary biomarker for early stages of age-related prostate carcinogenesis. Here, RBP4 is linked to prostatitis.